|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakaguchi M, Hisamori S, Oshima N, Sato F,
Shimono Y and Sakai Y: miR-137 regulates the tumorigenicity of
colon cancer stem cells through the inhibition of DCLK1. Mol Cancer
Res. 14:354–362. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pathak S, Meng WJ, Nandy SK, Ping J,
Bisgin A, Helmfors L, Waldmann P and Sun XF: Radiation and SN38
treatments modulate the expression of microRNAs, cytokines and
chemokines in colon cancer cells in a p53-directed manner.
Oncotarget. 6:44758–44780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakai H, Sato A, Aihara Y, Ikarashi Y,
Midorikawa Y, Kracht M, Nakagama H and Okamoto K: MKK7 mediates
miR-493-dependent suppression of liver metastasis of colon cancer
cells. Cancer Sci. 105:425–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagaraju GP, Madanraj AS, Aliya S, Rajitha
B, Alese OB, Kariali E, Alam A and El-Rayes BF: MicroRNAs as
biomarkers and prospective therapeutic targets in colon and
pancreatic cancers. Tumour Biol. 37:97–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao YQ, Chen X, Wang P, Lu L, Zhao W, Chen
C, Chen CP, Tao T, Sun J, Zheng YY, et al: Regulation of DLK1 by
the maternally expressed miR-379/miR-544 cluster may underlie
callipyge polar overdominance inheritance. Proc Natl Acad Sci USA.
112:pp. 13627–13632. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song W, Mu H, Wu J, Liao M, Zhu H, Zheng
L, He X, Niu B, Zhai Y, Bai C, et al: miR-544 regulates dairy goat
male germline stem cell self-renewal via targeting PLZF. J Cell
Biochem. 116:2155–2165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song WQ, Gu WQ, Qian YB, Ma X, Mao YJ and
Liu WJ: Identification of long non-coding RNA involved in
osteogenic differentiation from mesenchymal stem cells using
RNA-Seq data. Genet Mol Res. 14:18268–18279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haga CL, Velagapudi SP, Strivelli JR, Yang
WY, Disney MD and Phinney DG: Small molecule inhibition of miR-544
biogenesis disrupts adaptive responses to hypoxia by modulating
ATM-mTOR signaling. ACS Chem Biol. 10:2267–2276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu P, Gu Y, Li L, Wang F and Qiu X:
miR-544a promotes breast cancer cell migration and invasion
reducing cadherin 1 expression. Oncol Res. 23:165–170. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mo X, Zhang F, Liang H, Liu M, Li H and
Xia H: miR-544a promotes the invasion of lung cancer cells by
targeting cadherina 1 in vitro. Onco Targets Ther. 7:895–900. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao L, Zhang Y, Deng X, Mo W, Yu Y and Lu
H: Transcription factor KLF4 regulates microRNA-544 that targets
YWHAZ in cervical cancer. Am J Cancer Res. 5:1939–1953.
2015.PubMed/NCBI
|
|
17
|
Zhi Q, Guo X, Guo L, Zhang R, Jiang J, Ji
J, Zhang J, Zhang J, Chen X, Cai Q, et al: Oncogenic miR-544 is an
important molecular target in gastric cancer. Anticancer Agents Med
Chem. 13:270–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanaka Y, Muramatsu T, Uetake H, Kozaki K
and Inazawa J: miR-544a induces epithelial-mesenchymal transition
through the activation of WNT signaling pathway in gastric cancer.
Carcinogenesis. 36:1363–1371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarver AL, Thayanithy V, Scott MC,
Cleton-Jansen AM, Hogendoorn PC, Modiano JF and Subramanian S:
MicroRNAs at the human 14q32 locus have prognostic significance in
osteosarcoma. Orphanet J Rare Dis. 8:72013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thayanithy V, Sarver AL, Kartha RV, Li L,
Angstadt AY, Breen M, Steer CJ, Modiano JF and Subramanian S:
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Bone. 50:171–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma R, Zhang G, Wang H, Lv H, Fang F and
Kang X: Downregulation of miR-544 in tissue, but not in serum, is a
novel biomarker of malignant transformation in glioma. Oncol Lett.
4:1321–1324. 2012.PubMed/NCBI
|
|
22
|
Bhattacharyya NP, Das E, Bucha S, Das S
and Choudhury A: Regulation of cell cycle associated genes by
microRNA and transcription factor. Microrna. 5:180–200. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou T, Ou J, Zhao X, Huang X, Huang Y and
Zhang Y: MicroRNA-196a promotes cervical cancer proliferation
through the regulation of FOXO1 and p27Kip1. Br J Cancer.
110:1260–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao XC, Yu Y, Hou LK, Sun XH, Ge J, Zhang
B and Wang X: miR-142-3p inhibits cancer cell proliferation by
targeting CDC25C. Cell Prolif. 49:58–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res. 36:D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Markopoulos GS, Roupakia E, Tokamani M,
Chavdoula E, Hatziapostolou M, Polytarchou C, Marcu KB,
Papavassiliou AG, Sandaltzopoulos R and Kolettas E: A step-by-step
microRNA guide to cancer development and metastasis. Cell Oncol
(Dordr). 40:303–339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo Z, Zhang L, Li Z, Li X and Li G, Yu H,
Jiang C, Dai Y, Guo X, Xiang J and Li G: An in silico analysis of
dynamic changes in microRNA expression profiles in stepwise
development of nasopharyngeal carcinoma. BMC Med Genomics. 5:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shao H, Mohamed EM, Xu GG, Waters M, Jing
K, Ma Y, Zhang Y, Spiegel S, Idowu MO and Fang X: Carnitine
palmitoyltransferase 1A functions to repress FoxO transcription
factors to allow cell cycle progression in ovarian cancer.
Oncotarget. 7:3832–3846. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bicknell KA: Forkhead (FOX) transcription
factors and the cell cycle: Measurement of DNA binding by FoxO and
FoxM transcription factors. Methods Mol Biol. 296:247–262.
2005.PubMed/NCBI
|
|
31
|
Kuscu N and Celik-Ozenci C: FOXO1, FOXO3,
and FOXO4 are differently expressed during mouse oocyte maturation
and preimplantation embryo development. Gene Expr Patterns.
18:16–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Q, Sztukowska M, Ojo A, Scott DA,
Wang H and Lamont RJ: FOXO responses to Porphyromonas gingivalis in
epithelial cells. Cell Microbiol. 17:1605–1617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmidt M, Fernandez de Mattos S, van der
Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM and Medema RH:
Cell cycle inhibition by FoxO forkhead transcription factors
involves downregulation of cyclin D. Mol Cell Biol. 22:7842–7852.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang H and Tindall DJ: Dynamic FoxO
transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Gan B, Liu D and Paik JH: FoxO
family members in cancer. Cancer Biol Ther. 12:253–259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao F and Wang W: MicroRNA-96 promotes the
proliferation of colorectal cancer cells and targets tumor protein
p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1)
and FOXO3a. Mol Med Rep. 11:1200–1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M,
Zhu Y, Zhao Q, Dong YW, Shao K, et al: MicroRNA-223 regulates FOXO1
expression and cell proliferation. FEBS Lett. 586:1038–1043. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roy UK, Henkhaus RS, Ignatenko NA, Mora J,
Fultz KE and Gerner EW: Wild-type APC regulates caveolin-1
expression in human colon adenocarcinoma cell lines via FOXO1a and
C-myc. Mol Carcinog. 47:947–955. 2008. View Article : Google Scholar : PubMed/NCBI
|
